Identification
Personal identification
- Full name
- Karine Serre
- Gender
- Female
Citation names
- Serre, Karine
Author identifiers
- Ciência ID
- 1E11-7283-DF35
- ORCID iD
- 0000-0001-9152-4739
Email addresses
- karineserre@medicina.ulisboa.pt (Professional)
Telephones
- Telephone
-
- 217999549 (Professional)
Addresses
- Instituto de Medicina Molecular - Joao Lobo Antunes (IMM| JLA), Unit of "T cell Differentiation & Tumor Targeting". Instituto de Medicina Molecular - Joao Lobo Antunes, Av. Professor Egas Moniz, 1649-028, Lisboa, Lisboa, Portugal (Professional)
Websites
- https://www.researchgate.net/profile/Karine_Serre (Professional)
- https://pt.linkedin.com/in/karine-serre-4b1ba94 (Professional)
- http://orcid.org/0000-0001-9152-4739 (Professional)
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Immunology
- Medical and Health Sciences - Health Sciences
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
French (Mother tongue) | |||||
English | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
Portuguese | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) |
Education
Degree | Classification | |
---|---|---|
2002
Concluded
|
Immunology (Doutoramento)
Université de la Méditerranée, Aix-Marseille II, France
"Presentation of exogenous antigens by dendritic cells to CD4 and CD8 T cells, in vitro and in vivo" (THESIS/DISSERTATION)
|
PhD with honors |
1997
Concluded
|
DEA Immunology (Diplôme d´études supérieures)
Université de la Méditerranée, Aix-Marseille II, France
"Comparison of presentation of free antigen and liposome-encapsulated antigen, to antigen specific CD4 T cells, by bone marrow-derived
dendritic and antigen-specific splenic B cells." (THESIS/DISSERTATION)
|
13.89/20 Admitted 7th with 25 candidates |
1996
Concluded
|
DESS Immuno-Technology (Diplôme d´études supérieures)
Université de la Méditerranée, Aix-Marseille II, France
"Mouse model to study the effect of vaccination with an antigen from Staphylococus aureus to induce protective antibodies
against bovine mastitis caused by this pathogen." (THESIS/DISSERTATION)
|
12.5/20 Admitted 9th with 12 candidates |
1995
Concluded
|
Biochemistry and Immunology (Mestrado)
Université de la Méditerranée, Aix-Marseille II, France
"N/A" (THESIS/DISSERTATION)
|
13.72/20 Admitted 12th with 66 candidates |
1994
Concluded
|
Biochemistry (Licence)
Université de la Méditerranée, Aix-Marseille II, France
|
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2020 - 2026 | Principal Investigator (Research) | Fundação para a Ciência e a Tecnologia, Portugal |
Instituto de Medicina Molecular, Portugal | ||
2015/01/01 - 2019/12/31 | Principal Investigator (Research) | Fundação para a Ciência e a Tecnologia, Portugal |
Instituto de Medicina Molecular, Portugal | ||
2012/01/01 - 2014/12/31 | Postdoc (Research) | Fundação para a Ciência e a Tecnologia, Portugal |
Instituto de Medicina Molecular, Portugal | ||
2002 - 2011 | Postdoc (Research) | Birmingham MRC Centre for Immune Regulation, United Kingdom |
Birmingham MRC Centre for Immune Regulation, United Kingdom |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2018/11/02 - 2020/11/02 | Invited Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Medicina, Portugal |
Instituto de Medicina Molecular, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2021/06/01 - Current | Regulation of gamma-delta T cells in the tumor microenvironment and their manipulation towards immunotherapy of solid cancers
(250,000¿)
PTDC/MED-ONC/6829/2020
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2022/01/01 - 2024/12/31 | Dissect the tumor microenvironment to battle cancer radioresistance and immune escape
PTDC/MED-ONC/4165/2021
Fundação Champalimaud, Portugal
Universidade Nova de Lisboa, Portugal Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal Centro Hospitalar Universitário de São João, Portugal Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2021 - 2024 | Regulation of gamma-delta T cells in the tumor microenvironment and their manipulation towards effective immunotherapy of
solid cancers. Co-PI. (250,000 E).
PTDC/MED-ONC/6829/2020
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019 - 2021 | MAGICIAM: a MAcrophaGe Immunomodulatory-delivery system to prevent Cancer Invasion And Metastasis. (238,554€ - of which 12.500€
for iMM).
PTDC/BMT-SAL/031859/2017
Researcher
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019 - 2021 | Sub-therapeutic doses of ionizing radiation modulate the pre-metastatic niche and induce metastasis. Co-PI. (239,925 E).
PTDC/MED-OUT/031118/2017
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019 - 2021 | Programming anti-tumour myeloid cells to improve cancer immunotherapies. (239,896€).
PTDC/MED-IMU/30948/2017
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019 - 2021 | Sub-therapeutic doses of ionizing radiation modulate the pre-metastatic niche and induce metastasis. Co-PI. (239,925 E).
PTDC/MED-OUT/031118/2017
|
Fundação para a Ciência e a Tecnologia |
2017 - 2019 | Sulfur-containing amino acid dietary modulation of breast cancer immunity. (€25,000).
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundo iMM-Laço
Concluded
|
2016 - 2018 | Transcriptional (re)programming of antitumour myeloid cells in breast cancer. (€50,000).
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundo iMM-Laço
Concluded
|
2011 - 2011 | Identification of a key molecule for the differentiation of CD4 T helper 2 (Th2) cells and follicular T helper (TFh) cells
in vivo. (£2,195).
University of Birmingham Research Development Fund
Principal investigator
Birmingham MRC Centre for Immune Regulation, United Kingdom
|
Birmingham MRC Centre for Immune Regulation
Concluded
|
2011 - 2011 | Identification of a key molecule for the differentiation of CD4 T helper 2 (Th2) cells and follicular T helper (TFh) cells
in vivo. (£2,195).
University of Birmingham Research Development Fund
|
Birmingham MRC Centre for Immune Regulation |
2004 - 2009 | Regulation of extrafollicular antibody responses and plasma cell survival. (£1,218,000).
British Medical Research Council
Researcher
University of Birmingham College of Medical and Dental Sciences, United Kingdom
|
Medical Research Council
Concluded
|
2006 - 2007 | Extending the scope of single cell analysis of regulation of Th2-cytokine clustered genes among CD4 T helper cells. (£4,000).
University of Birmingham Scientific Projects Committee grant
Principal investigator
|
Birmingham MRC Centre for Immune Regulation
Concluded
|
2006 - 2007 | Extending the scope of single cell analysis of regulation of Th2-cytokine clustered genes among CD4 T helper cells. (£4,000).
University of Birmingham Scientific Projects Committee grant
|
Birmingham MRC Centre for Immune Regulation |
Contract
Designation | Funders | |
---|---|---|
2020 - 2025 | Bringing new allies to cancer therapy: How to instruct tumour-infiltrating myeloid cells to fight cancer?
CEECIND/00697/2018
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2022/01/01 - 2024/12/31 | combined immUNotherapeutIC approach for targeting bone marrow microenvironment in Multiple Myeloma
PTDC/MED-ONC/1215/2021
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Universidade Nova de Lisboa, Portugal Fundação Champalimaud, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2022/01/01 - 2023/12/31 | X-Chromosome Inactivation in Systemic Lupus Erythematosus
EXPL/MED-OUT/1517/2021
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018/10/15 - 2021/10/14 | MAGICIAM: um sistema imunomodelador de macrófagos para prevenir a invasão e metastização das células tumorais
PTDC/BTM-SAL/31859/2017
Instituto Nacional de Engenharia Biomédica, Portugal
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2015 - 2020 | Lineage-specific molecular networks that control production of pathogenic cytokines. (€180,000 for personal salary and €50,000
for the research project).
IF/00004/2014/CP1236/CT0006
Principal investigator
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2011 - 2015 | Intrinsic and extrinsic molecular controls of “inducible” versus “constitutive” production of IFN-g and IL-17 in TCRab CD4+
and TCRgd T cells in vivo. (€53,820).
SFRH/BPD/78039/2011.
Post-doc Fellow
Instituto de Medicina Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2009 - 2010 | Identifying novel transcription factors that drive CD4 T helper 2 cell differentiation in vivo. (£27,000).
Wellcome Trust Value in People Fellowship Bridging Award
Principal investigator
Birmingham MRC Centre for Immune Regulation, United Kingdom
|
Wellcome Trust
Concluded
|
2009 - 2010 | Identifying novel transcription factors that drive CD4 T helper 2 cell differentiation in vivo. (£27,000).
Wellcome Trust Value in People Fellowship Bridging Award
|
Birmingham MRC Centre for Immune Regulation |
2000 - 2001 | Exogenous antigen presentation by dendritic cells to CD4 and CD8 T cells, in vitro and in vivo. (€13,719).
ssociation Pour la Recherche sur le Cancer (ARC)
PhD Student Fellow
Fondation ARC pour la Recherche sur Le Cancer, France
|
Fondation ARC pour la Recherche sur Le Cancer
Concluded
|
2000 - 2001 | Exogenous antigen presentation by dendritic cells to CD4 and CD8 T cells, in vitro and in vivo. (¿13,719).
ssociation Pour la Recherche sur le Cancer (ARC)
|
Fondation ARC pour la Recherche sur Le Cancer |
1997 - 2000 | Etude des propriété de présentation antigénique par les cellules dendritiques dérivées de la moelle osseuse in vitro. (€ 37,800).
MNRT-13-1996
PhD Student Fellow
Aix-Marseille Université, France
|
Gouvernement francais Ministere de l'education nationale
Concluded
|
Outputs
Publications
Book chapter |
|
Conference paper |
|
Conference poster |
|
Journal article |
|
Other
Other output |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2020/03 | Cancer Immunotherapy – Lymphocytes to fight Cancer, mainly CAR T-Cells and gd T-Cells | VIII AEICBAS Biomedical Congress
(Porto, Portugal)
|
2020/02/26 | Bringing new allies to cancer therapy: i) How to instruct myeloid cells to fight cancer?, ii) Methionine increases the efficacy of anti-PD-1. | Invited Talk
Universidade de Aveiro (Aveiro, Portugal)
|
2019/06 | Immunotherapy in cancer | The European Human Genetics Conference (ESGH)
(Gothenburg, Sweden)
|
2019/03 | Why so much hope about immunotherapy? | XI Jornadas de Genética e Biotecnologia I Jornadas Ibéricas de Genética y Biotecnología
Universidade de Trás-os-Montes e Alto Douro (UTAD) (Vila Real, Portugal)
|
2018/11 | Different signalling pathways govern the emergence of macrophages and neutrophils with anti-tumour functions | Regulatory myeloid cells (MRC) in health and Disease – COST- Action – Annual Meeting
(Essen, Germany)
|
2018/06 | Different signalling pathways govern the emergence of macrophages and neutrophils with anti-tumour functions | 8th International conference on tumour microenvironment: progression, therapy and prevention
(Lisboa, Portugal)
|
2018/05 | Why so much hope about immunotherapy? | 2nd Symposium of the MSc in Oncology
(Porto, Portugal)
|
2018/04 | Different signalling pathways govern the emergence of macrophages and neutrophils with anti-tumour functions | 25th Porto CANCER meeting: Cancer Wars the immune force awakens
(Porto, Portugal)
|
2017/11 | Host: Harnessing the power of the immune system is key | CUF International meeting on cancer innovation
(Porto (10th Nov), Liboa (11th Nov) , Portugal)
|
2017/06 | Anti-tumour macrophages: myth or reality? | Symposium on Immunomodulation in Cancer & Regeneration
(Porto, Portugal)
|
2017/03 | Role of neutrophils in IL-17-dependent tumours: Tumour-associated neutrophils inhibit pro-tumour IL-17-producing gd T cells | Regulatory myeloid cells (MRC) in health and Disease – COST- Action – 4th ECI Workshop
(Brno, Czech Republic)
|
2016/04 | Tumour-associated neutrophils inhibit pro-tumour IL17-producing gamma-delta T cells | 2nd ASPIC international congress
(Porto, Portugal)
|
2015/06 | In vivo inhibition of tumour-associated IL-17-producing gd T cells by neutrophils | Seventh International ¿d T-Cell Conference
(London, United Kingdom)
|
2013/11 | In vivo molecular signatures of stable versus plastic gamma delta T cell subsets | Congrès Annuel de la Société Française d’Immunologie (SFI)
(Paris, France)
|
2013/11 | In vivo molecular signatures of stable versus plastic gamma delta T cell subsets | SPI Annual Meeting
(Coimbra, Portugal)
|
2013/10 | In vivo molecular signatures of stable versus plastic gamma delta T cell subsets that promote inflammation | 1st IMM Post-doc Symposium
(Lisboa, Portugal)
|
2013/06 | Regulation of IL-17 and IFN-g expression in gd T cells | Invited Talk
Centre d'Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée (Marseille, France)
|
2013/06 | Regulation of IL-17 and IFN-g expression in gd T cells | Invited Talk
Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Université de Nice-Sophia Antipolis (Nice, France)
|
2013/05 | Regulation of IL-17 and IFN-g expression in gd T cells | 16e Colloque Cytokines et Chimiokines du Croisic (CCCC16)
(Croisic, France)
|
2009/06 | GATA-3, c-Maf, Helios mRNA expression related to Th2-cytokine control in T cells responding in vivo | 16th Germinal Centre Conference
(Franckfurt, Germany)
|
2007 | Early emergence of diversity in T cells making a primary Th2 response | 13th International Congress of Immunology
(Rio de Janeiro, Brazil)
|
2001/05 | In vitro and ex vivo characterization of dendritic cells as the major cell type responsible for liposome capture in lymph nodes and for presentation of liposome-encapsulated antigen to CD4+ and CD8+ T cells | European Network of Immunology Institutes, ENII Conference
(Iles des Embiez, France)
|
2000/11 | Présentation antigénique dans le contexte des molécules du CMH de classe II et de classe I par les cellules dendritiques in vitro et in vivo | Club Francophone des Cellules Dendritiques (CFDC)
(Paris, France)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2021 - Current | Combined immUNotherapeutIC approach for targeting bone marrow microenvironment in Multiple Myeloma
Co-supervisor of Ana Raquel Vicente Lopes
|
Programa Champalimaud de Investigação Portugal (PhD)
Fundação Champalimaud, Portugal
|
2021 - Current | Single-cell transcriptomics in unravelling the complexity of the breast tumour microenvironment
Co-supervisor of Ana Marta Fernandes Bica
|
CAML PhD program (PhD)
Instituto de Medicina Molecular, Portugal
|
2020 - Current | Monocytes/macrophages as allies against cancer: how to instruct them to protect primary tumour growth and prevent metastasis?
Supervisor of Carolina Jardim
|
PhD - FCT fellowship (PhD)
Instituto de Medicina Molecular, Portugal
|
2019 - Current | Programming macrophages for effective immunotherapy
Supervisor of Afonso Teixeira da Mota
|
M.Sc. student FMUL 4th Oncobiology edition (Master)
Instituto de Medicina Molecular, Portugal
|
2017 - Current | Targeted delivery of carbon monoxide using artificial metalloantibodies for cancer immunotherapy
Co-supervisor of Carlos Diogo Labão Sousa de Almeida
|
PhD - LisbonBiomed (PhD)
Instituto de Medicina Molecular, Portugal
|
2019 - 2021 | Manipulation of the myeloid compartiment to improve cancer immunotherapy
Supervisor of Mariana Reis Sobreiro
|
Post-Doc
Instituto de Medicina Molecular, Portugal
|
2016 - 2020 | Regulation of T cell fitness and function in tumour responses
Co-supervisor of Sofia Mensurado Santos
|
PhD - LisbonBiomed (PhD)
Instituto de Medicina Molecular, Portugal
|
2019 - 2019 | Lymphoid and myeloid cell responses and metabolic fitness in the tumour microenvironment
Co-supervisor of Tommaso Scolaro
|
ERASMUS (Master)
Instituto de Medicina Molecular, Portugal
|
2018 - 2018 | Characterisation of anti-tumour macrophages in vitro and in vivo
Supervisor of Henning Boekoff
|
ERASMUS (Master)
Instituto de Medicina Molecular, Portugal
|
2017 - 2018 | Methionine supplementation improves the efficacy of breast cancer immunotherapy
Supervisor of Tiago Roberto Gomes Pestana
|
M.Sc. student Faculdade de Ciências e Tecnologia (Master)
Universidade Nova de Lisboa, Portugal
|
2017 - 2018 | Programming anti tumour myeloid cells for effective immunotherapy
Supervisor of Raquel Lopes
|
M.Sc. student FMUL 3rd Oncobiology edition (Master)
Instituto de Medicina Molecular, Portugal
|
2016 - 2017 | Characterization of anti tumour myeloid cells in a mouse model of transplantable mammary tumour
Supervisor of Miguel Alexandre Ferreira Pinto
|
M.Sc. Instituto de Ciências Biomédicas Abel Salazar (Master)
Universidade do Porto, Portugal
|
2014 - 2015 | Crosstalk between protective lymphoid and immunosuppressive myeloid tumour infiltrating cells
Supervisor of Sofia Mensurado Santos
|
M.Sc. FCUL 1st Biochemistry (Master)
Instituto de Medicina Molecular, Portugal
|
2013 - 2015 | Regulation of gd T cell effector functions
Supervisor of Joana Barros-Martins
|
M.Sc. FCUL 1st Biochemistry (Master)
Instituto de Medicina Molecular, Portugal
|
2013 - 2013 | The role of the transcription factor BATF in gd T cell differentiation and functionality
Co-supervisor of Michael Hamm
|
Master Cellular and molecular biology at University Pierre et Marie Curie (UPMC) (Master)
Instituto de Medicina Molecular, Portugal
|
2012 - 2013 | Effector gd T cells: Cytokine expression and regulation
Co-supervisor of Ingrid Brok
|
Master Cell Biology and Immunology Group at the Wageningen University, The Netherlands (Master)
Instituto de Medicina Molecular, Portugal
|
2006 - 2010 | Description of the microenvironment supporting plasmablast maturation and survival in lymph nodes
Co-supervisor of Elodie Mohr
|
Post-Doc
Birmingham MRC Centre for Immune Regulation, United Kingdom
|
2007 - 2007 | Role of IL-4 in inducing the follicular T cell differentiation in vivo
Co-supervisor of Julie Losbtein
|
Master Ecole Supérieure de Biotechnologie de Strasbourg, France (Master)
Birmingham MRC Centre for Immune Regulation, United Kingdom
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2023/10/03 - 2023/10/04 | Two Days Training School: "Brainstorming on analysis of multiplexed images" of the COST action CA20117 - Mye-InfoBank (2023/10/03 - 2023/10/04)
Workshop (Co-organisor)
|
Katholieke Universiteit Leuven Bibliotheken, Belgium |
2018/01/01 - 2018/06/14 | 8th International conference on tumour microenvironment: progression, therapy and prevention. Lisboa (Portugal). (2018)
Conference (Member of the Organising Committee)
|
|
2014/01/01 - 2014/10/15 | 40th Annual Meeting of the Portuguese Society for Immunology (SPI). IMM - Lisboa (Portugal). (2014/10/13 - 2014/10/15)
Meeting (Member of the Organising Committee)
|
Instituto de Medicina Molecular, Portugal |
2013/10/30 - 2013/10/30 | One-day workshop on “grant writing”. Dr. Judith Swan (Princeton University – USA). IMM - Lisboa (Portugal). (2013/10/30 - 2013/10/30)
Workshop (Member of the Organising Committee)
|
Instituto de Medicina Molecular, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2018/06/06 - 2018/06/09 | Different signalling pathways govern the emergence of macrophages and neutrophils with anti-tumour functions.
Poster Presentation
Conference
|
TOLL 2018- Editing innate immunity |
2018/04/16 - 2018/04/18 | Different signalling pathways govern the emergence of macrophages and neutrophils with anti-tumour functions.
Poster Presentation
Conference
|
Regulatory myeloid cells (MRC) in health and Disease – COST- Action – 5th ECI Workshop |
2017/09/03 - 2017/09/04 | A macrophage-centric view of cancer - Anti-tumour macrophages: myth or reality?
Poster Presentation
Conference
|
CRUK Beatson Institute: Understanding immunology Workshop |
2017/06/14 - 2017/06/16 | Anti-tumour macrophages: myth or reality?
Poster Presentation
Meeting
|
SPI Annual Meeting |
2016/04/10 - 2016/04/14 | Tumour-associated neutrophils inhibit pro-tumour IL17-producing gd T cells.
Poster Presentation
Conference
|
Keystone symposia: Myeloid Cells (D3) |
2015/09/14 - 2015/09/16 | Sometimes myeloid suppressive cells get it wrong: tumour-associated neutrophils inhibit pro-tumour IL-17-producing gd T cells.
Poster Presentation
Conference
|
Regulatory myeloid cells (MRC) in health and Disease – COST- Action – Conference and Workshop. |
2014/05/31 - 2014/06/02 | Unconventional functions of “master” transcription factors in gd T cells.
Poster Presentation
Conference
|
Sixth International gd T-Cell Conference - Chicago |
2012/11/26 - 2012/11/28 | Transcriptional and epigenetic signatures of IFN-g+ or IL-17+ gd T cell subsets.
Poster Presentation
Meeting
|
SPI Annual Meeting |
2012/09/05 - 2012/09/08 | Transcriptional and epigenetic signatures of pro-inflammatory gd T cell subsets.
Poster Presentation
Congress
|
3rd European Congress of Immunology |
2012/05/31 - 2012/06/02 | Transcriptional and epigenetic mechanisms of differentiation of pro-inflammatory gd T cell subsets.
Poster Presentation.
Conference
|
Fifth International gd T-Cell Conference |
2011/11/29 - 2011/11/30 | Selective effects of NF-kB1 deficiency in CD4 T cells on Th2 and TFh induction by alum-precipitated protein vaccines.
Poster Presentation
Meeting
|
SPI Annual Meeting |
2010/12/06 - 2010/12/10 | Selective effects of NF-kB1 deficiency in CD4 T cells on Th2 and TFh induction by alum-precipitated protein vaccines.
Poster Presentation
Meeting
|
BSI Annual Meeting |
2009 - 2009 | Expression of GATA-3, c-Maf and Helios transcription factor mRNA by CD4 T cells responding to Th2 antigen in vivo.
Poster Presentation
Congress
|
European Congress of Immunology |
1997/11/26 - 1997/11/28 | The antigen presenting functions of surface immunoglobulin on B cells and Fc receptors on dendritic cells are analogous.
Poster presentation.
Congress
|
Congrès Annuel de la Société Française d’Immunologie (SFI) |
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2019/06/17 | Intercellular relationships in the tumor microenvironment: implications for cancer pathophysiology
(Thesis) Main arguer
|
Ana Isabel Ferreira de Oliveira (PhD)
Universidade do Minho Escola de Medicina, Portugal
|
2019/04/01 | Thymic activities in the establishment of tumor immune tolerance
(Thesis) Arguer
|
José Guilherme Pereira de Almeida Santos (PhD)
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2018/10/12 | Plasmodium berghei liver infection inhibition by host immune response to Trypanosoma brucei
(Thesis) Main arguer
|
Rafael Alexandre Carvalho Luís (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2020 - Current | Associação Portuguesa de Investigação em Cancro (ASPIC) | Member |
2012 - Current | Sociedade Portuguesa de Imunologia (SPI) | Member |
2005 - Current | British Society of Immunology (BSI) | Member |
2000 - Current | Société Française d'Immunologie (SFI) | Member |
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2023/02 - Current | Portuguese Immuno-Oncology SPO-SPI Group
Member
|
|
2018/09/01 - 2021 | Board of Direction of the Sociedade Portuguesa de Imunologia (SPI).
Other
|
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2022/12 - Current | Licenciatura Cienca da Nutricao - Innate Immunity – Pattern Recognition Receptors | Innate Immunity – Pattern Recognition Receptors (Licenciatura) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2022/12 - Current | Licenciatura Cienca da Nutricao - Macrophages and Dendritic cells | Macrophages and Dendritic cells (Licenciatura) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2022/12 - Current | Licenciatura Cienca da Nutricao - Inflammation | Inflammation (Licenciatura) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2022/10 - Current | Mestrado Integrado em Medicina - 2 year - Practicals - Innate Immunity | TRONCO COMUM II. A) MICROBIOLOGIA, IMUNIDADE E INFECCIOLOGIA – 2º ANO (Mestrado integrado) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2019/12/14 - Current | Licenciatura Cienca da Nutricao - Tumour Immunology | Tumour Immunology (Licenciatura) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2019/11/12 - Current | Licenciatura Cienca da Nutricao - Caloric restriction and immune response | Caloric restriction and immune response (Licenciatura) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2019/01/05 - Current | Licenciatura Cienca da Nutricao - Cancer Immunotherapy | Cancer Immunotherapy (Licenciatura) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2021/02/02 - 2021/02/05 | UC Oncoimunologia - MSc/CE Oncobiologia | Leukocyte subsets in the tumour microenvironment - Tumour immunity (Mestrado) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2020/12/12 - 2020/12/14 | Universidade Lusófona | Lymphoid and Myeloid cell in Tumours. Harnessing the power of the immune system: Immunotherapy (Ensino básico 3º ciclo) | Universidade Lusófona, Portugal |
2020/10/20 - 2020/10/20 | Mestrado integrado em ciências farmacêuticas -“Alvos Terapêuticos e Biomarcadores” and “Oncobiologia e Medicina de Precisão” | Immunotherapeutic Strategies Against Cancer”. (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2020/01/28 - 2020/01/28 | Lisbon BioMed PhD Program | Tumour immunity: focus on myeloid cells (Doutoramento) | Instituto de Medicina Molecular, Portugal |
2019/12/09 - 2019/12/09 | MCDIE Mestrado de doenças infecciosas | Diversification of T helper cell functions (Mestrado) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2019/11/26 - 2019/11/26 | Mestrado integrado em ciências farmacêuticas Modulo: Alvos Terapêuticos e Biomarcadore | Harnessing the immune system for immunotherapy (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2019/04/17 - 2019/04/17 | 4º ano do Mestrado Integrado em Ciências Farmacêuticas | Why so much hope about immunotherapy? Harnessing the power of the immune system: Immunotherapy (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2019/04/08 - 2019/04/08 | 3rd year Medical students | Oncobiology: On the Cancer & the Host (Especialização pós-licenciatura) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2019/02/05 - 2019/02/05 | Mestrado em Oncobiologia – Módulo de Oncoimunologia | Leukocyte subsets in the tumour microenvironment - Tumour immunity (Mestrado) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2018/11/11 - 2018/11/11 | Life health and sciences (2 years) | Tumour Immunology (Licenciatura) | Centro Académico de Medicina de Lisboa (CAML), Portugal |
2018/06/21 - 2018/06/21 | GABBA PhD program of the University of Porto | Immune subsets in the tumour microenvironment and their role during (immuno)therapies (Doutoramento) | Universidade do Porto, Portugal |
2018/05/11 - 2018/05/11 | 2nd Symposium of the MSc in Oncology, Porto | Why so much hope about immunotherapy? (Licenciatura) | Universidade do Porto, Portugal |
2018/02/05 - 2018/02/05 | LisbonBioMed PhD student Programme | Immunology course: “Diversification of T helper cell functions”. (Doutoramento) | iMM-JLA / LisbonBioMed PhD student Programme, Portugal |
2018/01/16 - 2018/01/16 | LisbonBioMed PhD student Programme | Immunology course: “Tumour immunology and Cancer Immunotherapy”. (Doutoramento) | iMM-JLA / LisbonBioMed PhD student Programme, Portugal |
2017/11/06 - 2017/11/17 | MCDIE Mestrado de doenças infecciosas | Diversification of T helper cell responses (Mestrado) | A Faculdade de Medicina da Universidade de Lisboa (FMUL), Portugal |
2017/02/02 - 2017/02/02 | LisbonBioMed PhD student Programme | Diversification of T helper cell responses (Doutoramento) | iMM-JLA / LisbonBioMed PhD student Programme, Portugal |
2017/01/11 - 2017/01/11 | Mestrado em Oncobiologia – Módulo de Oncoimunologia | Leukocyte subsets in the tumor microenvironment (Mestrado) | Centro Académico de Medicina de Lisboa (CAML), Portugal |
2016/02/01 - 2016/02/01 | LisbonBioMed PhD student Programme | Effector T cells (Doutoramento) | iMM-JLA / LisbonBioMed PhD student Programme, Portugal |
2015/02/02 - 2015/02/02 | LisbonBioMed master student Programme | Innate gd T cell functional differentiation (Mestrado) | Universidade de Lisboa Faculdade de Ciências, Portugal |
2014/02/04 - 2014/02/04 | LisbonBioMed PhD student Programme | Molecular mechanisms of T cell differentiation (Doutoramento) | Instituto de Medicina Molecular, Portugal |
2013/06/03 - 2013/06/05 | Nanocourse CAML PhD Programme | Challenges in Immunology: Challenges in T cell differentiation (Doctor) | Centro Académico de Medicina de Lisboa (CAML), Portugal |
2009/09 - 2009/12 | Small Group Teaching for Medical students (2nd year MBChB) (15 tutorials) | 2nd year MBChB (Magister (2nd cycle)) | University of Birmingham College of Medical and Dental Sciences, United Kingdom |
1999 - 2000 | Teaching Pratical Lab courses: ELISA test and Immuno-electrophoresis. | Bachelor degree in Immunology | Aix-Marseille Université, France |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2019/01/01 - Current | Targeting the CCL2-CCR2 axis in metastatic medulloblastoma. | Carlos Manuel Tavares Da Custodia (PhD thesis committee) |
2018/01/01 - Current | Mechanisms of T follicular regulatory cell differentiation. | Filipa Ramos de Moura Ribeiro (PhD thesis committee) |
2016/01/01 - Current | Transcriptomics of the follicular regulatory T cells analysed at the single cell levels. | Saumya Dileep Kumar (PhD thesis committee) |
2017 - 2020/07 | Translating Breast Cancer Immune Features Into Biomarkers and Therapies | Diana Isabel Pereira Saraiva (PhD thesis committee) |
2016/01/01 - 2018/12/30 | Follicular regulatory T cells in human diseases. | Válter Bruno Ribeiro Fonseca (PhD thesis committee) |
2013/01/01 - 2015/12/30 | Follicular regulatory T cells. | Ana Raquel Maceira (PhD thesis committee) |
Other jury / evaluation
Activity description | Institution / Organization | |
---|---|---|
2018 - 2019 | Reviewer of grant applications for "Prémios Pfizer " | Pfizer Portugal, Portugal |
2018 - 2018 | Reviewer of grant applications for the caritative association "Breast Cancer Now" | Breast Cancer Now, United Kingdom |
Distinctions
Award
2023 | Gilead Génese Program award (10,000€).
Gilead Sciences Lda, Portugal
|
2018 | Prémio de Investigação FAZCiência 2018 (3rd place).
Fundação AstraZeneca e a Sociedade Portuguesa de Oncologia, Portugal
|
2018 | First prize of the 2nd Edition of the Prémio Janssen Inovação (€30,000).
Janssen-Cilag Farmacêutica Lda, Portugal
|
2017 | Best Oral Presentation - Symposium on Immunomodulation in Cancer & Regeneration I3S/IPO-Porto, PORTUGAL |
2014 | Best Poster Award - SPI Annual Meeting (€500)
Sociedade Portuguesa de Imunologia, Portugal
|
2013 | Travel Grant Award (500€)
Sociedade Portuguesa de Imunologia, Portugal
|
2012 | Travel Grant Award (€500)
Sociedade Portuguesa de Imunologia, Portugal
|